{"id":13009,"date":"2018-04-05T18:09:34","date_gmt":"2018-04-05T16:09:34","guid":{"rendered":"https:\/\/news.embl.de\/?p=13009"},"modified":"2024-07-23T17:10:05","modified_gmt":"2024-07-23T15:10:05","slug":"pdx-finder-cancer-models","status":"publish","type":"post","link":"https:\/\/www.embl.org\/news\/science\/pdx-finder-cancer-models\/","title":{"rendered":"PDX Finder &#8211; Free global portal for cancer models"},"content":{"rendered":"\n<article class=\"vf-card vf-card--brand vf-card--bordered vf-u-margin__bottom--800\" default>\n  <div class=\"vf-card__content | vf-stack vf-stack--400\">\n      <h3 class=\"vf-card__heading\">\n      Update    <\/h3>\n                <p class=\"vf-card__text\">PDX Finder has now been redeveloped and renamed to <a class=\"vf-card_link\" href=\"https:\/\/www.cancermodels.org\/\">CancerModels.org<\/a>.<\/p>\n      <\/div>\n<\/article>\n\n\n\n\n<p>The European Bioinformatics Institute (EMBL-EBI) and <a href=\"http:\/\/www.jax.org\/\" target=\"_blank\" rel=\"noopener noreferrer\">The Jackson Laboratory (JAX)<\/a> have jointly developed the first open cancer research portal for Patient Derived Xenograft (PDX) models. The freely available <a href=\"http:\/\/www.pdxfinder.org\/\" target=\"_blank\" rel=\"noopener noreferrer\">PDX Finder<\/a> is hosted by EMBL-EBI and catalogues PDX models from numerous global repositories. The PDX Finder web portal offers significant potential for collaborative research, as well as time savings for researchers, who now only have to search one central catalogue instead of going through a range of individual and distributed resources.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Clinically relevant<\/h2>\n\n\n\n<p>Researchers create PDX mouse models by implanting tumour fragments from cancer patients into mice with suppressed immune function. These models give researchers an idea of how a specific patient would react to a specific drug.<\/p>\n\n\n\n<p>\u201cPreclinical models such as PDX models are very important predictors of the efficacy of anticancer therapies, which currently have a high failure rate in clinical trials,\u201d says Nathalie Conte, PDX Finder Project Lead at EMBL-EBI. \u201cCancer models are essential for understanding and treating cancer. PDX models are increasingly recognised as clinically relevant because they retain the patient tumour characteristics and imitate a specific patient\u2019s response to drugs more accurately than other models. However, until now, there was no open central catalogue for PDX models. PDX Finder enables cancer researchers to search through a wider variety of models more quickly. This saves valuable time and enables collaborations.\u201d<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Centralised catalogue<\/h2>\n\n\n\n<p>As the use of PDX models increases, so does the need to for a central repository for these models. PDX Finder joins together many of these individual efforts, as it builds on The Jackson Laboratory\u2019s PDX resource which was developed in partnership with more than 20 medical centres in the United States, and EMBL-EBI\u2019s membership of <a href=\"http:\/\/europdx.eu\/\" target=\"_blank\" rel=\"noopener noreferrer\">EurOPDX<\/a>. This ensures that the scope and reach of PDX Finder is wider than any other individual resource available.<\/p>\n\n\n\n<p>\u201cBoth EMBL-EBI and JAX received independent funding from the National Cancer Institute for projects that included implementation of online catalogues for PDX models,\u201d noted Carol Bult, Scientific Director of the JAX PDX Resource. \u201cBoth groups had the goal to help basic and clinical cancer researchers find relevant models fast. With approval from the NCI, we instead collaborated to build a single, unified portal with international scope.\u201d<\/p>\n\n\n\n<p>The initial release of PDX Finder contains over 1900 models from multiple repositories. The models spancancers of the digestive system, respiratory tract, skin, breast, urinary system and more.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">High quality models<\/h2>\n\n\n\n<p>The launch of the PDX Finder comes just months after EMBL-EBI and The Jackson Laboratory published the <a href=\"https:\/\/www.ebi.ac.uk\/about\/news\/press-releases\/PDX-minimal-information\" target=\"_blank\" rel=\"noopener noreferrer\">PDX Minimal Information standard<\/a>, which sets standards for basic information needed to describe essential properties of a PDX model. The standard was the result of a significant community effort that involved over 30 academic and commercial institutes globally. The standard ensures that every model in PDX Finder is carefully described to help researchers choose the most relevant ones.<\/p>\n\n\n\n<p>Researchers can search for PDX models and submit their own on the PDX Finder website: <a href=\"http:\/\/www.pdxfinder.org\" target=\"_blank\" rel=\"noopener noreferrer\">www.pdxfinder.org<\/a>.<\/p>\n\n\n\n<p>This post was originally published on <a href=\"https:\/\/www.ebi.ac.uk\/about\/news\/press-releases\/pdx-finder-cancer-models\" target=\"_blank\" rel=\"canonical nofollow noopener noreferrer\" data-href=\"https:\/\/www.ebi.ac.uk\/about\/news\/press-releases\/pdx-finder-cancer-models\">EMBL-EBI News.<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Launch of the first free global online catalogue of PDX models<\/p>\n","protected":false},"author":47,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[2,17591],"tags":[28,38,36,184],"embl_taxonomy":[],"class_list":["post-13009","post","type-post","status-publish","format-standard","hentry","category-science","category-science-technology","tag-bioinformatics","tag-cancer","tag-embl-ebi","tag-model-organism"],"acf":{"article_intro":"<p>First global online catalogue of PDX models facilitates collaboration and helps cancer researchers save valuable time<\/p>\n","related_links":[{"link_description":"","link_url":""},{"link_description":"","link_url":""}],"article_sources":false,"vf_locked":false,"featured":false,"color":"#007B53","show_featured_image":false,"field_target_display":"embl","field_article_language":{"value":"english","label":"English"},"source_article":false,"in_this_article":false,"press_contact":"None","article_translations":false,"languages":""},"embl_taxonomy_terms":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>PDX Finder - Free global portal for cancer models<\/title>\n<meta name=\"description\" content=\"PDX Finder is the first open and free global online catalogue for Patient Derived Xenograft (PDX) models, which are increasingly used in cancer research\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.embl.org\/news\/science\/pdx-finder-cancer-models\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PDX Finder - Free global portal for cancer models\" \/>\n<meta property=\"og:description\" content=\"PDX Finder is the first open and free global online catalogue for Patient Derived Xenograft (PDX) models, which are increasingly used in cancer research\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.embl.org\/news\/science\/pdx-finder-cancer-models\/\" \/>\n<meta property=\"og:site_name\" content=\"EMBL\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/embl.org\/\" \/>\n<meta property=\"article:published_time\" content=\"2018-04-05T16:09:34+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-07-23T15:10:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2017\/07\/EMBL_logo_colour.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1638\" \/>\n\t<meta property=\"og:image:height\" content=\"783\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Oana Stroe\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@embl\" \/>\n<meta name=\"twitter:site\" content=\"@embl\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Oana Stroe\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/www.embl.org\/news\/science\/pdx-finder-cancer-models\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.embl.org\/news\/science\/pdx-finder-cancer-models\/\"},\"author\":{\"name\":\"Oana Stroe\",\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/person\/95d28f359cc138357c5dcf79319ef414\"},\"headline\":\"PDX Finder &#8211; Free global portal for cancer models\",\"datePublished\":\"2018-04-05T16:09:34+00:00\",\"dateModified\":\"2024-07-23T15:10:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.embl.org\/news\/science\/pdx-finder-cancer-models\/\"},\"wordCount\":507,\"publisher\":{\"@id\":\"https:\/\/www.embl.org\/news\/#organization\"},\"keywords\":[\"bioinformatics\",\"cancer\",\"embl-ebi\",\"model organism\"],\"articleSection\":[\"Science\",\"Science &amp; Technology\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.embl.org\/news\/science\/pdx-finder-cancer-models\/\",\"url\":\"https:\/\/www.embl.org\/news\/science\/pdx-finder-cancer-models\/\",\"name\":\"PDX Finder - Free global portal for cancer models\",\"isPartOf\":{\"@id\":\"https:\/\/www.embl.org\/news\/#website\"},\"datePublished\":\"2018-04-05T16:09:34+00:00\",\"dateModified\":\"2024-07-23T15:10:05+00:00\",\"description\":\"PDX Finder is the first open and free global online catalogue for Patient Derived Xenograft (PDX) models, which are increasingly used in cancer research\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.embl.org\/news\/science\/pdx-finder-cancer-models\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.embl.org\/news\/#website\",\"url\":\"https:\/\/www.embl.org\/news\/\",\"name\":\"European Molecular Biology Laboratory News\",\"description\":\"News from the European Molecular Biology Laboratory\",\"publisher\":{\"@id\":\"https:\/\/www.embl.org\/news\/#organization\"},\"alternateName\":\"EMBL News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.embl.org\/news\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.embl.org\/news\/#organization\",\"name\":\"European Molecular Biology Laboratory\",\"alternateName\":\"EMBL\",\"url\":\"https:\/\/www.embl.org\/news\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png\",\"contentUrl\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png\",\"width\":300,\"height\":144,\"caption\":\"European Molecular Biology Laboratory\"},\"image\":{\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/embl.org\/\",\"https:\/\/x.com\/embl\",\"https:\/\/www.instagram.com\/embl_org\/\",\"https:\/\/www.linkedin.com\/company\/15813\/\",\"https:\/\/www.youtube.com\/user\/emblmedia\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/person\/95d28f359cc138357c5dcf79319ef414\",\"name\":\"Oana Stroe\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/105fb83bbeaf64062ef1f4608964e5163ac52f590628df2ffde6de9a0d85af80?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/105fb83bbeaf64062ef1f4608964e5163ac52f590628df2ffde6de9a0d85af80?s=96&d=mm&r=g\",\"caption\":\"Oana Stroe\"},\"description\":\"Oana Stroe is a PR specialist and copywriter with experience in engineering, IT and life sciences. She now collects and shares remarkable science stories.\",\"url\":\"https:\/\/www.embl.org\/news\/author\/oana-stroe-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-3\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PDX Finder - Free global portal for cancer models","description":"PDX Finder is the first open and free global online catalogue for Patient Derived Xenograft (PDX) models, which are increasingly used in cancer research","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.embl.org\/news\/science\/pdx-finder-cancer-models\/","og_locale":"en_US","og_type":"article","og_title":"PDX Finder - Free global portal for cancer models","og_description":"PDX Finder is the first open and free global online catalogue for Patient Derived Xenograft (PDX) models, which are increasingly used in cancer research","og_url":"https:\/\/www.embl.org\/news\/science\/pdx-finder-cancer-models\/","og_site_name":"EMBL","article_publisher":"https:\/\/www.facebook.com\/embl.org\/","article_published_time":"2018-04-05T16:09:34+00:00","article_modified_time":"2024-07-23T15:10:05+00:00","og_image":[{"width":1638,"height":783,"url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2017\/07\/EMBL_logo_colour.png","type":"image\/png"}],"author":"Oana Stroe","twitter_card":"summary_large_image","twitter_creator":"@embl","twitter_site":"@embl","twitter_misc":{"Written by":"Oana Stroe","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/www.embl.org\/news\/science\/pdx-finder-cancer-models\/#article","isPartOf":{"@id":"https:\/\/www.embl.org\/news\/science\/pdx-finder-cancer-models\/"},"author":{"name":"Oana Stroe","@id":"https:\/\/www.embl.org\/news\/#\/schema\/person\/95d28f359cc138357c5dcf79319ef414"},"headline":"PDX Finder &#8211; Free global portal for cancer models","datePublished":"2018-04-05T16:09:34+00:00","dateModified":"2024-07-23T15:10:05+00:00","mainEntityOfPage":{"@id":"https:\/\/www.embl.org\/news\/science\/pdx-finder-cancer-models\/"},"wordCount":507,"publisher":{"@id":"https:\/\/www.embl.org\/news\/#organization"},"keywords":["bioinformatics","cancer","embl-ebi","model organism"],"articleSection":["Science","Science &amp; Technology"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.embl.org\/news\/science\/pdx-finder-cancer-models\/","url":"https:\/\/www.embl.org\/news\/science\/pdx-finder-cancer-models\/","name":"PDX Finder - Free global portal for cancer models","isPartOf":{"@id":"https:\/\/www.embl.org\/news\/#website"},"datePublished":"2018-04-05T16:09:34+00:00","dateModified":"2024-07-23T15:10:05+00:00","description":"PDX Finder is the first open and free global online catalogue for Patient Derived Xenograft (PDX) models, which are increasingly used in cancer research","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.embl.org\/news\/science\/pdx-finder-cancer-models\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.embl.org\/news\/#website","url":"https:\/\/www.embl.org\/news\/","name":"European Molecular Biology Laboratory News","description":"News from the European Molecular Biology Laboratory","publisher":{"@id":"https:\/\/www.embl.org\/news\/#organization"},"alternateName":"EMBL News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.embl.org\/news\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.embl.org\/news\/#organization","name":"European Molecular Biology Laboratory","alternateName":"EMBL","url":"https:\/\/www.embl.org\/news\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/","url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png","contentUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png","width":300,"height":144,"caption":"European Molecular Biology Laboratory"},"image":{"@id":"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/embl.org\/","https:\/\/x.com\/embl","https:\/\/www.instagram.com\/embl_org\/","https:\/\/www.linkedin.com\/company\/15813\/","https:\/\/www.youtube.com\/user\/emblmedia\/"]},{"@type":"Person","@id":"https:\/\/www.embl.org\/news\/#\/schema\/person\/95d28f359cc138357c5dcf79319ef414","name":"Oana Stroe","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.embl.org\/news\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/105fb83bbeaf64062ef1f4608964e5163ac52f590628df2ffde6de9a0d85af80?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/105fb83bbeaf64062ef1f4608964e5163ac52f590628df2ffde6de9a0d85af80?s=96&d=mm&r=g","caption":"Oana Stroe"},"description":"Oana Stroe is a PR specialist and copywriter with experience in engineering, IT and life sciences. She now collects and shares remarkable science stories.","url":"https:\/\/www.embl.org\/news\/author\/oana-stroe-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-3\/"}]}},"field_target_display":"embl","field_article_language":{"value":"english","label":"English"},"fimg_url":false,"featured_image_src":"https:\/\/www.embl.org\/news\/wp-includes\/images\/media\/default.svg","_links":{"self":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts\/13009","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/users\/47"}],"replies":[{"embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/comments?post=13009"}],"version-history":[{"count":9,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts\/13009\/revisions"}],"predecessor-version":[{"id":67427,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts\/13009\/revisions\/67427"}],"wp:attachment":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/media?parent=13009"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/categories?post=13009"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/tags?post=13009"},{"taxonomy":"embl_taxonomy","embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/embl_taxonomy?post=13009"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}